4.5 Article

Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats

Journal

Publisher

BMC
DOI: 10.1186/s13018-020-02151-1

Keywords

Osteoporotic bone defect; Alendronate; Carbamazepine; Regeneration

Categories

Funding

  1. National Natural Science Foundation of China [81341054, 81171732]
  2. Wannan Medical College [PF2019005, YR201917]
  3. Technology Mountaineering Program of Yijishan Hospital

Ask authors/readers for more resources

The study revealed that ovariectomy altered bone microstructural parameters, and the use of CBZ further reduced bone mass with ALN treatment preventing bone loss. ALN effectively reversed the effects of CBZ and promoted local bone neoformation in rats with osteoporosis.
BackgroundThe use of antiepileptic drugs and estrogen deficiency put forward higher requirements for bone defect regeneration. The present study investigated the effects of alendronate (ALN) on femoral bone defect in ovariectomized (OVX) rats under the influence of carbamazepine (CBZ).MethodsOne hundred female SD rats at 3months of age were either sham-operated or OVX and divided into four groups: sham control (CON); OVX control (OVX); ovariectomized rats treated with CBZ via gavage (75mg/kg/day; CBZ); ovariectomized rats treated with CBZ plus ALN (2mg/kg/day; CBZ-ALN). A critical-sized femoral metaphyseal bone defect was established in all female SD rats. Animals from the CBZ and CBZ-ALN groups received drugs by gavage the day after bone defect surgery was performed. After the rats were sacrificed, the defected area located in the distal femur was harvested for evaluation by microcomputed tomography (micro-CT), hematoxylin and eosin (HE) staining, and Masson's trichrome staining. The samples were also analyzed by biomechanics and immunohistochemical evaluation (IHC). Besides, biochemical analysis evaluates all serum samples.ResultsThe present study showed that ovariectomy changed the microstructural parameters of bone. The use of CBZ further decreased femur bone mass while treatment with ALN prevented bone loss. Compared to OVX and CBZ groups, CBZ-ALN group promoted bone neoformation and enhanced the ultimate load of the femur bone. However, the group of CBZ-ALN did not return to normal levels compared with the CON group. Besides, we noticed that CBZ-ALN group reduced tartrate-resistant acid phosphatase-5b (Tracp-5b) expression and had no significant effect on the expression of osteocalcin (OCN) and type I collagen (Col-I) in IHC compared with CBZ group. Biochemical analysis results presented that systemic delivery of CBZ showed pernicious effects on bone formation and resorption in ovariectomized rats, with the worse effects on C-terminal crosslinked telopeptide of type I collagen (CTX-1). Besides, a significant decrease in CTX-1 levels was observed in CBZ-ALN group as compared to the group of CBZ.ConclusionThese results demonstrated that ALN can effectively reverse the effects of CBZ on the microarchitectural properties of bone, and thus can have a positive effect on local bone neoformation in rats with osteoporosis.Clinical relevanceThe dose of 2mg/kg ALN improves the negative effect of prescription of CBZ at 75mg/kg and promotes bone neoformation of femoral bony deficits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available